206 related articles for article (PubMed ID: 2752713)
21. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
22. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Leclercq R; Duval J
Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
[TBL] [Abstract][Full Text] [Related]
23. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
Paisley JW; Washington JA
Antimicrob Agents Chemother; 1978 Aug; 14(2):224-7. PubMed ID: 308792
[TBL] [Abstract][Full Text] [Related]
24. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
Fuchs PC; Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
Fuchs PC; Barry AL; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
[TBL] [Abstract][Full Text] [Related]
26. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
27. Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.
Tausk F; Stratton CW
Antimicrob Agents Chemother; 1986 Oct; 30(4):584-9. PubMed ID: 3098162
[TBL] [Abstract][Full Text] [Related]
28. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
Barry AL
Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
[TBL] [Abstract][Full Text] [Related]
29. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
Boon RJ; Beale AS; Sutherland R
Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
[TBL] [Abstract][Full Text] [Related]
30. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
Traub WH; Spohr M
Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
[TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility of bacteria to a ticarcillin-clavulanic acid combination.
Sparks SE; Jones RL; Kilgore WR
Am J Vet Res; 1988 Dec; 49(12):2038-40. PubMed ID: 3239838
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Machka K; Dickert H; Braveny I
Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
[TBL] [Abstract][Full Text] [Related]
34. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
[TBL] [Abstract][Full Text] [Related]
35. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
36. Ticarcillin/clavulanic acid: determination of minimal inhibitory concentrations against bacterial strains isolated from patients in intensive care units. Comparison with other agents.
Pasargiklian I; Lusco G; Paizis G; Mascheroni E
J Chemother; 1996 Apr; 8(2):113-21. PubMed ID: 8708742
[TBL] [Abstract][Full Text] [Related]
37. In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.
Henry D; Skidmore AG; Ngui-Yen J; Smith A; Smith JA
Antimicrob Agents Chemother; 1985 Aug; 28(2):259-64. PubMed ID: 3869433
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibilities of feline and canine Escherichia coli and Pseudomonas spp. isolates to ticarcillin and ticarcillin-clavulanic acid.
Bennett AB; Martin PA; Gottlieb SA; Govendir M
Aust Vet J; 2013 May; 91(5):171-8. PubMed ID: 23614511
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
Watanakunakorn C; Glotzbecker C
J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Lyon MD; Smith KR; Saag MS; Cloud GA; Cobbs CG
Antimicrob Agents Chemother; 1986 Jul; 30(1):25-30. PubMed ID: 3092731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
